Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 8 (EEF1A1P8)
- Target
- EEF1A1P8
- Molecular classification
- Other, Pseudogene
01
Overview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 8 (EEF1A1P8) is a processed pseudogene located in the human genome (chromosome 3q27.1). It is one of many non-coding pseudogenes derived from the functional gene EEF1A1, which encodes a protein critical for the elongation step of mRNA translation. Unlike its parent gene, EEF1A1P8 does not produce a functional protein and is not involved in cellular signaling, receptor function, enzymatic activity, or transporter activity. It is not a conventional therapeutic target, and no drugs, disease associations, or biomarker roles have been directly attributed to this pseudogene. Its existence exemplifies gene evolutionary processes such as retrotransposition. The aliases EEF1AL6 and eukaryotic translation elongation factor 1 alpha-like 6 pseudogene refer to the same genetic locus. In summary, EEF1A1P8 is a human processed pseudogene, not a receptor, enzyme, drug target, or biomarker. It has no established biological or clinical role except as a noncoding genetic element, and its main scientific relevance is as a member of the pseudogene family of EEF1A1 alpha subunit.
- Other names
- EEF1A1P8EEF1AL6eukaryotic translation elongation factor 1 alpha-like 6 pseudogene
02
Mechanism of action
None. No drugs act via this pseudogene.
03
Biological functions
As a processed pseudogene, it has no known biological function. Functional protein activities pertain to its parent, EEF1A1, which is involved in protein biosynthesis and cellular processes.
04
Disease associations
No direct disease roles have been established for EEF1A1P8 itself. Some EEF1A1 pseudogenes are speculatively linked to various cancers and disorders (see Table 1B in reference), but EEF1A1P8 itself is not specifically associated with any disease at present.
05
Safety considerations
None. As a pseudogene, it poses no direct therapeutic or safety challenges.
06
Interacting drugs
None. As a non-coding pseudogene, there are no drugs known to interact with EEF1A1P8.
07
Biomarkers
None identified. Pseudogenes are sometimes explored as biomarkers, but there is no known biomarker status for EEF1A1P8 at present.
Beyond the preview
Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 8 (EEF1A1P8).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 8 (EEF1A1P8).